In this text-based CE Snips activity, experts in the field review promising emerging therapeutics for retinal diseases, evaluate their potential clinical impact, and discuss strategies for incorporating them into current treatment algorithms.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
254 of 254 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Article / monograph / reference
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedJul 13, 2026
-
Last day to claim creditJul 13, 2027 9 months left
-
Answers in CME Inc. (AiCME) Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies
-
Impact Education +1 Advanced Clinical Updates in Retinal Diseases for Managed Care Professionals
-
Paradigm Medical Communications, LLC The Many Faces of Neovascular Retinal Disease: Individualizing the Use of Sustained Delivery Therapy
